FGFR1-induced epithelial to mesenchymal transition through MAPK/PLCγ/COX-2-mediated mechanisms.
about
A place for precision medicine in bladder cancer: targeting the FGFRs.NCAM and FGFR1 coexpression and colocalization in renal tumorsFibroblast growth factor receptors-1 and -3 play distinct roles in the regulation of bladder cancer growth and metastasis: implications for therapeutic targeting.FGFR4 role in epithelial-mesenchymal transition and its therapeutic value in colorectal cancerUpregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway.CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activitiesIsolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method.Development and characterisation of a 3D multi-cellular in vitro model of normal human breast: a tool for cancer initiation studiesMiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transitionGenome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells.Lentivirus-mediated PLCγ1 gene short-hairpin RNA suppresses tumor growth and metastasis of human gastric adenocarcinoma.Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.Role of the fibroblast growth factor receptor axis in cholangiocarcinoma.Chronic inflammation in urothelial bladder cancer.An IonStar Experimental Strategy for MS1 Ion Current-Based Quantification Using Ultrahigh-Field Orbitrap: Reproducible, In-Depth, and Accurate Protein Measurement in Large Cohorts.Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges.Unraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signatures.Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism.Beyond epithelial-to-mesenchymal transition: Common suppression of differentiation programs underlies epithelial barrier dysfunction in mild, moderate, and severe asthma.FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients.Bladder cancer.Laminar inflammatory events in lean and obese ponies subjected to high carbohydrate feeding: Implications for pasture-associated laminitis.Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.
P2860
Q30249143-36D3E66B-7AE7-4B06-8350-CD6F3484E065Q33582911-DB769B9E-7953-436F-A9CD-940DE7465350Q34611953-6B184FDA-61F6-4D30-9ACC-3A401F1948F6Q34733972-65C44196-43FC-4C5B-8831-38C26292A73CQ35781460-B4B28F72-434C-46B0-B7B3-61055A80EF79Q35828490-F6AE43D3-EC7C-49B5-9524-BFF9375EF4D1Q35842078-5B04DC23-F941-4D5A-8161-07C2A7826F98Q35955429-CAAFA76E-BA21-409C-A5F8-96EDF4753DAFQ36546530-A4F10EB9-A52F-4C95-8272-7FD8C99F3C46Q36872440-0B337735-D207-447F-9556-69D3B988DFEFQ36946711-2FDF3FE2-6B42-41C1-B941-5596DDF8BBC0Q38297729-86847A9D-0E52-4C8C-9EDB-7EB65A48E98BQ38354294-22D901A4-318F-4FB4-8A37-698435AE0F6CQ38564597-CA9474F7-71EE-4AAA-9411-3E443F969604Q38835346-D5C07BDA-3D8D-46C1-BB22-E20F9F9570F4Q39254523-A6E17735-36E4-4995-ACA4-3C7D7BF31DC6Q39568069-D2FE2F96-1A6E-45D0-8663-1F255C25E92CQ41243144-C0752349-E1C7-444E-828F-E88A39DA8031Q47135891-B307CE94-6F63-4946-A5E1-7184401A9E4AQ48298703-7C3C01A2-E8F5-454E-8B59-EAD55D3AD72DQ48564245-D7080233-5D03-4F50-8AD8-0960C685A29EQ52810295-A288552C-9EFA-4B54-9F70-044D4B2F59FDQ54200903-CDEA7238-C3F5-418F-B61F-A28CE5769033Q54985778-254C3675-E43C-4F8B-ABA3-2976F2EE2C7B
P2860
FGFR1-induced epithelial to mesenchymal transition through MAPK/PLCγ/COX-2-mediated mechanisms.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
FGFR1-induced epithelial to me ...... LCγ/COX-2-mediated mechanisms.
@ast
FGFR1-induced epithelial to me ...... LCγ/COX-2-mediated mechanisms.
@en
FGFR1-induced epithelial to me ...... LCγ/COX-2-mediated mechanisms.
@en-gb
FGFR1-induced epithelial to me ...... LCγ/COX-2-mediated mechanisms.
@nl
type
label
FGFR1-induced epithelial to me ...... LCγ/COX-2-mediated mechanisms.
@ast
FGFR1-induced epithelial to me ...... LCγ/COX-2-mediated mechanisms.
@en
FGFR1-induced epithelial to me ...... LCγ/COX-2-mediated mechanisms.
@en-gb
FGFR1-induced epithelial to me ...... LCγ/COX-2-mediated mechanisms.
@nl
prefLabel
FGFR1-induced epithelial to me ...... LCγ/COX-2-mediated mechanisms.
@ast
FGFR1-induced epithelial to me ...... LCγ/COX-2-mediated mechanisms.
@en
FGFR1-induced epithelial to me ...... LCγ/COX-2-mediated mechanisms.
@en-gb
FGFR1-induced epithelial to me ...... LCγ/COX-2-mediated mechanisms.
@nl
P2860
P50
P1433
P1476
FGFR1-induced epithelial to me ...... LCγ/COX-2-mediated mechanisms.
@en
P2093
Euan W Baxter
P2860
P304
P356
10.1371/JOURNAL.PONE.0038972
P407
P577
2012-06-12T00:00:00Z